1Y Close · As of Aug 26, 2026
Shaperon operates in the Pharmaceuticals sector.
Legal name: Shaperon Inc.
In fiscal year 2025, Shaperon (378800) reported revenue of 228 million KRW, up 1186.7% from 18 million KRW a year earlier.
Operating profit was -15.8 billion KRW and net income was -15.5 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 22.2 billion KRW, with a P/B of 0.90.
These figures can be verified in the DART filing (receipt no. 20260319000869).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 228M | -15.8B | -15.5B |
| 2024 | 18M | -15.1B | -14.9B |
| 2023 | 215M | -13.2B | -12.4B |
Recent Filings
Semi-Annual Report (2026.06)
Material Event Report (Early CB Retirement Decision)
Extraordinary Meeting Result
Checks
3 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-12 | Semi-Annual Report (2026.06) |
| 2026-08-11 | Material Event Report (Early CB Retirement Decision) |
| 2026-08-06 | Extraordinary Meeting Result |
| 2026-08-05 | Other Market Notice (Administrative Designation Concern) (Stock Price Below 1,000 KRW) |
| 2026-07-30 | 불성실공시법인미지정 (지정유예) |